Video

May 20, 2022

Dr. Joseph Jacob on the future of nonsurgical treatment in UTUC

Author(s):

“It’s an exciting time in UTUC,” says Joseph Jacob, MD.

In this video, Joseph Jacob, MD, talks about the future of nonsurgical treatment in upper tract urothelial carcinoma. Jacob is an assistant professor of urology at SUNY Upstate Medical University in Syracuse, New York.

Related Content

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com

November 18th 2024

Expert robotic surgeon discusses da Vinci 5, advances in urologic surgery

Ronney Abaza, MD, FACS

"It's actually a very exciting time to be a robotic surgeon," says Ronney Abaza, MD, FACS.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com

November 16th 2024

Expert discusses current trials in bladder cancer to watch for

Jason M. Hafron, MD, CMO

"Bladder cancer is exploding. [It] is exciting, it's changing, and we're just at the start of this," says Jason M. Hafron, MD, CMO.

May 28th 2023

2023 AUA highlights in benign urology

Urology Times staff

Gopal H. Badlani, MD, and Steven A. Kaplan, MD, discuss some of the notable abstracts in benign urology that were presented at the 2023 AUA Annual Meeting.

Blur image of hospital | Image Credit: © jakkapan - stock.adobe.com

November 15th 2024

Gautam Jayram, MD, on the top 5 things to know in bladder and kidney cancer

Gautam Jayram, MD

"We...talked a little bit about BCG-unresponsive disease, which is a really hot topic; a lot of trials and a lot of data are coming there," says Gautam Jayram, MD.

Prostate cancer cells | Image Credit: © Dr_Microbe - stock.adobe.com

November 15th 2024

Scott Eggener, MD, on a pragmatic approach to prostate cancer innovations

Benjamin P. Saylor

“You have to be balanced in what to embrace vs what not. It is easy to be wowed by new things," said Scott Eggener, MD.

Related Content

November 18th 2024

Expert robotic surgeon discusses da Vinci 5, advances in urologic surgery

Ronney Abaza, MD, FACS

"It's actually a very exciting time to be a robotic surgeon," says Ronney Abaza, MD, FACS.

November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

November 16th 2024

Expert discusses current trials in bladder cancer to watch for

Jason M. Hafron, MD, CMO

"Bladder cancer is exploding. [It] is exciting, it's changing, and we're just at the start of this," says Jason M. Hafron, MD, CMO.

May 28th 2023

2023 AUA highlights in benign urology

Urology Times staff

Gopal H. Badlani, MD, and Steven A. Kaplan, MD, discuss some of the notable abstracts in benign urology that were presented at the 2023 AUA Annual Meeting.

November 15th 2024

Gautam Jayram, MD, on the top 5 things to know in bladder and kidney cancer

Gautam Jayram, MD

"We...talked a little bit about BCG-unresponsive disease, which is a really hot topic; a lot of trials and a lot of data are coming there," says Gautam Jayram, MD.

November 15th 2024

Scott Eggener, MD, on a pragmatic approach to prostate cancer innovations

Benjamin P. Saylor

“You have to be balanced in what to embrace vs what not. It is easy to be wowed by new things," said Scott Eggener, MD.